These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10346064)

  • 1. A panorama of cardiac risk.
    Titus K
    CAP Today; 1999 Feb; 13(2):1, 18-20, 22 passim. PubMed ID: 10346064
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrinogen and factor VII as risk factors in vascular disease.
    Hultin MB
    Prog Hemost Thromb; 1991; 10():215-41. PubMed ID: 2008532
    [No Abstract]   [Full Text] [Related]  

  • 3. [When will fibrinogen screening become available?].
    Ernst E
    Dtsch Med Wochenschr; 1991 Dec; 116(49):1888-9. PubMed ID: 1743100
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibrinogen: the plot thickens.
    Ernst E
    J Clin Epidemiol; 1992 May; 45(5):561-2. PubMed ID: 1588362
    [No Abstract]   [Full Text] [Related]  

  • 5. Coronary atherogenic risk factors in women.
    Stangl V; Baumann G; Stangl K
    Eur Heart J; 2002 Nov; 23(22):1738-52. PubMed ID: 12419293
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular events with increased lipoprotein-associated phospholipase A(2) and low high-density lipoprotein-cholesterol: the Veterans Affairs HDL Intervention Trial.
    Robins SJ; Collins D; Nelson JJ; Bloomfield HE; Asztalos BF
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1172-8. PubMed ID: 18356553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on stroke and blood lipid level].
    Xu H; Yang Q; Tang B
    Zhonghua Yu Fang Yi Xue Za Zhi; 1998 Nov; 32(6):366-8. PubMed ID: 10374589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New and classical risk factors--the Münster heart study (PROCAM).
    Assmann G; Schulte H; Cullen P
    Eur J Med Res; 1997 Jun; 2(6):237-42. PubMed ID: 9182651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggregation of lipoprotein and inflammatory parameters in families with a history of premature myocardial infarction: the Tallinn myocardial infarction study.
    Aasvee K; Kurvinen E; Sundvall J; Jauhiainen M; Tur I
    Clin Chem Lab Med; 2008; 46(11):1602-8. PubMed ID: 19012525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homocysteine in lipoprotein apheresis patients--retrospective data analysis in apheresis center of a university hospital.
    Tselmin S; Rodionov RN; Müller G; Bornstein S; Julius U
    Atheroscler Suppl; 2013 Jan; 14(1):123-8. PubMed ID: 23357153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of tibolone therapy on lipids and coagulation indices.
    Daher R; Al-Amin H; Beaini M; Usta I
    Clin Chem Lab Med; 2006; 44(12):1498-9. PubMed ID: 17163831
    [No Abstract]   [Full Text] [Related]  

  • 12. Homocysteine increases the risk associated with hyperlipidaemia.
    Daly C; Fitzgerald AP; O'Callaghan P; Collins P; Cooney MT; Graham IM;
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):150-5. PubMed ID: 19276985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid paradox in acute myocardial infarction-the association with 30-day in-hospital mortality.
    Cheng KH; Chu CS; Lin TH; Lee KT; Sheu SH; Lai WT
    Crit Care Med; 2015 Jun; 43(6):1255-64. PubMed ID: 25738856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
    Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
    Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.
    Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
    Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Blood lipid patterns in ischemic heart disease and cerebrovascular diseases].
    Gaglio M; Caruso G; Milone A; Trovato GM; Vancheri FS
    Cardiologia; 1984; 29(3-4):203-10. PubMed ID: 6541939
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum lipid profiles and homocysteine levels in adults with stroke or myocardial infarction in the town of Gombe in northern Nigeria.
    Glew RH; Okolie H; Crossey M; Suberu O; Trujillo M; Pereyra M; Vanderjagt DJ
    J Health Popul Nutr; 2004 Dec; 22(4):341-7. PubMed ID: 15663167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance of non-high-density lipoprotein cholesterol and its application in pediatrics].
    Chen LH; Shi XF; Liang L
    Zhonghua Er Ke Za Zhi; 2013 Jun; 51(6):436-8. PubMed ID: 24120061
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of non-high-density lipoprotein cholesterol in predicting cerebrovascular events in patients following myocardial infarction.
    Mahajan N; Ference BA; Arora N; Madhavan R; Bhattacharya P; Sudhakar R; Sagar A; Wang Y; Sacks F; Afonso L
    Am J Cardiol; 2012 Jun; 109(12):1694-9. PubMed ID: 22465317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of fluvastatin on homocysteine and serum lipids in kidney allograft recipients.
    Małyszko J; Małyszko JS; Brzósko S; Pawlak K; Myśliwiec M
    Ann Transplant; 2002; 7(1):52-4. PubMed ID: 12221904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.